Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00925093

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Three different antibiotics are used to prevent infection in case of neurosurgery - this study examines to which extent the antibiotics penetrate from the blood to the cerebrospinal fluid (surrounding the brain).

Conditions

Interventions

TypeNameDescription
DRUGVancomycinVancomycin is administered intravenously and subsequently measured in cerebrospinal fluid sample
DRUGTeicoplaninTeicoplanin is administered intravenously and subsequently measured in cerebrospinal fluid sample
DRUGLinezolidLinezolid is administered intravenously and subsequently measured in cerebrospinal fluid sample

Timeline

Start date
2011-09-01
Primary completion
2012-12-01
Completion
2013-12-01
First posted
2009-06-19
Last updated
2015-01-26

Source: ClinicalTrials.gov record NCT00925093. Inclusion in this directory is not an endorsement.